L. A. Leiter

970 total citations
14 papers, 561 citations indexed

About

L. A. Leiter is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. A. Leiter has authored 14 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. A. Leiter's work include Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Diabetes Treatment and Management (3 papers). L. A. Leiter is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Diabetes Treatment and Management (3 papers). L. A. Leiter collaborates with scholars based in Canada, United Kingdom and United States. L. A. Leiter's co-authors include Hertzel C. Gerstein, S. J. Meltzer, Bernard Zinman, Denis Daneman, Jean‐François Yale, Sora Ludwig, David C.W. Lau, Ross D. Feldman, Martin G. Myers and Ellen Burgess and has published in prestigious journals such as American Journal of Clinical Nutrition, European Heart Journal and BMJ.

In The Last Decade

L. A. Leiter

14 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. A. Leiter Canada	9	181	179	133	118	68	14	561
LA Leiter Canada	13	181 1.0×	152 0.8×	90 0.7×	94 0.8×	80 1.2×	18	517
Dachuan Gu China	15	123 0.7×	222 1.2×	85 0.6×	78 0.7×	68 1.0×	28	484
R LEWANCZUK Canada	15	241 1.3×	247 1.4×	117 0.9×	94 0.8×	105 1.5×	19	614
Luis Alcocer Mexico	13	102 0.6×	300 1.7×	83 0.6×	81 0.7×	52 0.8×	59	620
Fadi El‐Atat United States	9	259 1.4×	254 1.4×	83 0.6×	75 0.6×	99 1.5×	16	626
Guido Garavelli Italy	14	165 0.9×	357 2.0×	93 0.7×	89 0.8×	35 0.5×	23	640
L. Romayne Kurukulasuriya United States	12	253 1.4×	202 1.1×	62 0.5×	74 0.6×	105 1.5×	21	609
A Sturani Italy	13	90 0.5×	419 2.3×	121 0.9×	69 0.6×	51 0.8×	58	792
Sipke T. Visser Netherlands	15	96 0.5×	155 0.9×	112 0.8×	63 0.5×	35 0.5×	28	641
George Panotopoulos Greece	10	279 1.5×	172 1.0×	154 1.2×	108 0.9×	171 2.5×	11	587

Countries citing papers authored by L. A. Leiter

Since Specialization

Citations

This map shows the geographic impact of L. A. Leiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. A. Leiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. A. Leiter more than expected).

Fields of papers citing papers by L. A. Leiter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. A. Leiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. A. Leiter. The network helps show where L. A. Leiter may publish in the future.

Co-authorship network of co-authors of L. A. Leiter

This figure shows the co-authorship network connecting the top 25 collaborators of L. A. Leiter. A scholar is included among the top collaborators of L. A. Leiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. A. Leiter. L. A. Leiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

O’Donoghue, Michelle L., Eri Kato, Ofri Mosenzon, et al.. (2021). The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus. Diabetologia. 64(6). 1226–1234. 17 indexed citations

Köenig, Wolfgang, Kausik K. Ray, Ulf Landmesser, et al.. (2021). Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials. European Heart Journal. 42(Supplement_1). 2 indexed citations

Köenig, Wolfgang, Kausik K. Ray, Ulf Landmesser, et al.. (2021). Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials. European Heart Journal. 42(Supplement_1). 3 indexed citations

Stoekenbroek, Robert M., Kausik K. Ray, Ulf Landmesser, et al.. (2019). 4945Inclisiran-mediated reductions in Lp(a) in the ORION-1 trial. European Heart Journal. 40(Supplement_1). 4 indexed citations

Aroda, Vanita R., Timothy S. Bailey, Bertrand Cariou, et al.. (2014). PO424 THE EFFECT OF INSULIN DEGLUDEC IN COMBINATION WITH LIRAGLUTIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES REQUIRING TREATMENT INTENSIFICATION. Diabetes Research and Clinical Practice. 106. S261–S262. 3 indexed citations

Shen, Long, Eric Reyes, Laine Thomas, et al.. (2013). Role of diuretics, blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. BMJ. 347(dec09 7). f6745–f6745. 87 indexed citations

Jenkins, David J.A., Laura Chiavaroli, Julia MW Wong, et al.. (2010). Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Canadian Medical Association Journal. 182(18). 1961–1967. 60 indexed citations

Lindsay, Thomas F., et al.. (2006). Perceptions of Canadian Vascular Surgeons toward Pharmacological Risk Reduction in Patients with Peripheral Arterial Disease. Annals of Vascular Surgery. 20(5). 555–563. 19 indexed citations

Leiter, L. A., et al.. (1999). 2. Recommendations on obesity and weight loss. Canadian Medical Association Journal. 160(9). 7–12. 22 indexed citations

10.

Feldman, Ross D., Norman R.C. Campbell, Pierre Larochelle, et al.. (1999). 1999 Canadian recommendations for the management of hypertension. Canadian Medical Association Journal. 161(12). 81 indexed citations

11.

Meltzer, S. J., L. A. Leiter, Denis Daneman, et al.. (1998). 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.. PubMed. 159 Suppl 8. S1–29. 181 indexed citations

12.

Ogilvie, Richard I., Ellen Burgess, Jean R. Cusson, et al.. (1993). Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.. PubMed. 149(5). 575–84. 53 indexed citations

13.

Hrboticky, Nina, L. A. Leiter, & G. Harvey Anderson. (1989). Menstrual cycle effects on the metabolism of tryptophan loads. American Journal of Clinical Nutrition. 50(1). 46–52. 28 indexed citations

14.

Rifkin, Harold, et al.. (1962). Current concepts of diabetic microangiopathy.. PubMed. 11. 235–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact